Harrison Farber, MD
Enriched profileProfessor of Medicine; Director, Pulmonary Embolism Response Team (PERT), Pulmonary Hypertension Center · Tufts Medical Center
Harrison Farber is Professor of Medicine; Director, Pulmonary Embolism Response Team (PERT), Pulmonary Hypertension Center at Tufts Medical Center. OpenAlex indexes 471 publications with 19,363 citations (h-index 59); ClinicalTrials.gov lists 2 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Pulmonary Disease profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 14 Oct 2026
Harrison W. Farber, MD, is Professor of Medicine at Tufts Medical Center / Tufts University School of Medicine. The public record shows 471 publications with 19,363 citations (h-index 59), centered on Respiratory. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 38 companies, 6 NIH-funded awards (1985–2015).
- Most recent indexed publication: 2025 · Pulmonary therapy
- Top research focus: Respiratory
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 38 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 9 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
Industry payments
Updated 14 Oct 2026
38 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year202511 payments
- Actelion Pharmaceuticals US, Inc.Program year20258 payments
- United Therapeutics CorporationProgram year202512 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
48.9%Endothelin Receptor Antagonist27.7%Ambrisentan62%Opsumit25%Opsynvi13%Part D≥36 patientsLoop diuretic9.3%Furosemide72%Torsemide28%Part D≥36 patients+ 4 more classes in this area
Genitourinary & hormones
25.8%Phosphodiesterase 5 Inhibitor25.8%Tadalafil68%Sildenafil Citrate15%Alyq10%Adcirca7%Part D<11 patientsBlood & clotting
14%Prostacyclin Receptor Agonist6.1%Uptravi100%Part D≥17 patientsProstacycline Vasodilator5.9%Tyvaso Dpi65%Orenitram Er35%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 14 Oct 2026
6 NIH research awards on record, funded 1985–2015 per NIH RePORTER. The latest:
- Dimethyl Fumarate In Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
University of Pittsburgh at Pittsburgh
FY2017$236,840R21AR069285 - Biomarkers of Pulmonary Complications of Scleroderma: The SSc-PAH and
Boston University Medical Campus
FY2015$279,961P50AR060780 - Biomarkers of Pulmonary Complications of Scleroderma: The SSc-PAH and
Boston University Medical Campus
FY2014$289,730P50AR060780
Publications
Updated 14 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Pulmonary Arterial Wedge Oxygen Saturation: Does It Confirm Wedge Position in Patients With Pulmonary Hypertension?
Pulmonary circulation
Letter2025 - Characteristics of Patients with Pulmonary Arterial Hypertension Receiving Selexipag in the SPHERE Registry by Race and Ethnicity.
Journal of racial and ethnic health disparities
Article2025 - A Prospective Analysis of Vasoreactivity and Mortality in WHO Group 3 Pulmonary Hypertension.
Pulmonary circulation
Article2025 - Factors associated with discontinuation of treatment for pulmonary arterial hypertension in the United States.
Pulmonary circulation
Article2024
Online presence
Updated 14 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/harrison-farber-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Other
profiles.bumc.bu.edu/ProfileDetails.aspx
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.bumc.bu.edu ↗ - Other
bmc.org/findaphysician/PhysicianProfile.php
- Other
bu.edu/cort/key-personnel/harrison-farber-m-d-cort-co-director
- Other
bumc.bu.edu/pulmonary/people/faculty/harrisonfarber
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bumc.bu.edu ↗ - Other
facultyprofiles.tufts.edu/harrison-farber
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facultyprofiles.tufts.edu ↗
Mentions by others
where others cite or feature them- LinkedIn
linkedin.com/posts/phaware-global-association_im-aware-that-im-rare-the-phaware-podcast-activity-7117526165384286208-wnlq
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Other
teamphenomenalhope.org/about-us/board-of-directors
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →teamphenomenalhope.org ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
- Board Certified
Internal Medicine (American Board of Internal Medicine)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗ - Board Certified
Pulmonary Disease (American Board of Internal Medicine)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Editorial & leadership roles
journal and society appointments- Director
Pulmonary Embolism Response Team (PERT), Tufts Medical Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →teamphenomenalhope.org ↗ - Co-Director
Pulmonary Hypertension Center, Tufts Medical Center
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →tuftsphupdate.com ↗ - Professor of Medicine
Tufts University School of Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →bumc.bu.edu ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
- Top MD designation
Consumers' Checkbook
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Secondary affiliations
appointments beyond the home institution- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pub.orcid.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗
Media & interviews
press, podcasts and appearances- "I'm Aware That I'm Rare" (phaware podcast)
episode 435, interview on pulmonary arterial hypertension
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →phaware.medium.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Andrew Levey, MD
Tufts Medical Center
Mark Sarnak, MD
Tufts Medical Center
James Udelson, MD
Tufts Medical Center
Nicholas Hill, MD
Tufts Medical Center
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Marshall University
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital